Shares of Microsoft Corp. retreated from record levels on Thursday when an analyst downgraded the shares despite Wall Street’s general agreement that the software giant was well diversified to handle the challenges posed by COVID-19. Microsoft MSFT, -4.12% Shares fell to an intraday low of $ 204.42 and last lost …
Read More »Tesla’s stock options are priced for an unusually large move after earnings, but odds are against bettors
Tesla Inc.’s stock options imply a one-day post-earnings movement that is more than 60% higher than the historical average, but the odds are currently against investors willing to bet on such unusual volatility. The electric vehicle maker plans to report second-quarter results after Wednesday’s closing bell. The average estimates for …
Read More »Analyst says IBM stock earnings after earnings exceed, but “really important things” could be better
Shares of International Business Machines Corp. rose on Tuesday after the company beat expectations for the June quarter, but analysts did not give the company too much credit for clearing a low level. Mused Moffett, Nathanson analyst, Lisa Ellis: “We are still working to achieve the correct semantics: when companies …
Read More »AstraZeneca Covid-19 data looks positive, but falls short of last week’s hype
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »Investors applaud when two coronavirus vaccine candidates report T-cell responses, but findings are still at an early stage
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »